Promomed Promomed has set the IPO price at ₽400 per share, which corresponds to the upper end of the price range. Volume of placement amounted to about ₽6 billion, and the entire company is valued at ₽85 billion. Promomed will use the raised funds to develop, register and bring to market new innovative drugs, as well as consider options for partial deleveraging and c...